19-590007-G-GGCC
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 1P and 10B. PM4_SupportingBP6_ModerateBS1BS2
The NM_001194.4(HCN2):c.81_83dupGCC(p.Pro28dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00088 ( 1 hom., cov: 20)
Exomes 𝑓: 0.000064 ( 0 hom. )
Consequence
HCN2
NM_001194.4 disruptive_inframe_insertion
NM_001194.4 disruptive_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.460
Genes affected
HCN2 (HGNC:4846): (hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2) The protein encoded by this gene is a hyperpolarization-activated cation channel involved in the generation of native pacemaker activity in the heart and in the brain. The encoded protein is activated by cAMP and can produce a fast, large current. Defects in this gene were noted as a possible cause of some forms of epilepsy. [provided by RefSeq, Jan 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_001194.4. Strenght limited to Supporting due to length of the change: 1aa.
BP6
Variant 19-590007-G-GGCC is Benign according to our data. Variant chr19-590007-G-GGCC is described in ClinVar as [Likely_benign]. Clinvar id is 2357092.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.000882 (112/127052) while in subpopulation AFR AF= 0.00282 (100/35458). AF 95% confidence interval is 0.00237. There are 1 homozygotes in gnomad4. There are 60 alleles in male gnomad4 subpopulation. Median coverage is 20. This position pass quality control queck.
BS2
High AC in GnomAd4 at 112 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HCN2 | NM_001194.4 | c.81_83dupGCC | p.Pro28dup | disruptive_inframe_insertion | 1/8 | ENST00000251287.3 | NP_001185.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000866 AC: 110AN: 127064Hom.: 1 Cov.: 20
GnomAD3 genomes
AF:
AC:
110
AN:
127064
Hom.:
Cov.:
20
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000643 AC: 33AN: 513590Hom.: 0 Cov.: 4 AF XY: 0.0000499 AC XY: 12AN XY: 240392
GnomAD4 exome
AF:
AC:
33
AN:
513590
Hom.:
Cov.:
4
AF XY:
AC XY:
12
AN XY:
240392
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000882 AC: 112AN: 127052Hom.: 1 Cov.: 20 AF XY: 0.000973 AC XY: 60AN XY: 61642
GnomAD4 genome
AF:
AC:
112
AN:
127052
Hom.:
Cov.:
20
AF XY:
AC XY:
60
AN XY:
61642
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 19, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at